Back to Search
Start Over
Squalane-based emulsion vaccine delivery system: composition with murabutide activate Th1 response.
- Source :
-
Pharmaceutical development and technology [Pharm Dev Technol] 2019 Mar; Vol. 24 (3), pp. 269-275. Date of Electronic Publication: 2018 Jul 04. - Publication Year :
- 2019
-
Abstract
- Emulsions play an important role in present-day subunit vaccine delivery. Squalane-based emulsion was formulated using surfactants viz., Pluronic F68, Span 85 along with Murabutide (MB) as immunepotentiator. Particle size and zetapotential of the final optimized emulsion was found to be 134 nm and -13 mV, respectively. The in vitro cellular uptake studies performed using fluorescein isothiocyanate (FITC)-labeled ovalbumin (OVA) clearly revealed the rapid uptake of antigen in the presence of emulsion. The in vivo subcutaneous studies involving measurement of OVA-specific IgG antibody titers, Th1/Th2 cytokines were performed and a marked up regulation in IL-2, IL-12 and IFN-γ cytokines indicate Th1 immune response. Results supported that the squalane-based delivery system enhanced the uptake of the antigen by immune cells and elicited humoral as well as cell-mediated immune response in mice. These results indicate the promising application of the new squalane based oil-in-water (O/W) emulsion as capable vaccine delivery system useful for vaccine development.
- Subjects :
- Acetylmuramyl-Alanyl-Isoglutamine administration & dosage
Acetylmuramyl-Alanyl-Isoglutamine immunology
Animals
Antigens immunology
Cytokines immunology
Drug Delivery Systems
Emulsions
Fluorescein-5-isothiocyanate chemistry
Hexoses chemistry
Mice
Mice, Inbred BALB C
Ovalbumin administration & dosage
Ovalbumin immunology
Particle Size
Poloxamer chemistry
RAW 264.7 Cells
Squalene chemistry
Surface-Active Agents chemistry
Th1 Cells immunology
Th2 Cells immunology
Acetylmuramyl-Alanyl-Isoglutamine analogs & derivatives
Adjuvants, Immunologic administration & dosage
Squalene analogs & derivatives
Vaccines administration & dosage
Subjects
Details
- Language :
- English
- ISSN :
- 1097-9867
- Volume :
- 24
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- Pharmaceutical development and technology
- Publication Type :
- Academic Journal
- Accession number :
- 29688119
- Full Text :
- https://doi.org/10.1080/10837450.2018.1469150